Basic simulation training in endourology was established with the endoscopic stone treatment step 1(EST s1), which is now recognised worldwide for training and examination. Following on from EST s1, the EST s2 was started by the EAU sections.
We describe the methodology used in the development of Endoscopic Stone treatment step 2(EST s2) assessment curriculum.
The "full-life cycle curriculum development" template was followed for curriculum development, focussing on intermediate training of EST protocol with complex endourological tasks. A cognitive task analysis(CTA) was run in accordance with EAU Urolithiasis guidelines. The protocol and its details underwent a first consensus by Delphi method with EULIS(EAU Urolithiasis Section) experts in March 2017. Once the outcome and metrics were decided, curriculum development was carried out. Purpose-built stones were developed, and simulator system requirement was defined. Preliminary testing was done in EUREP 2019 and in phase five the protocol was finalised with full tutor instruction sheet.
The EST-s2/A curriculum development, took 38 months and involved EAU Uro-technology and urolithiasis sections with coordination from the European School of Urology (ESU) training group. Starting from the initial CTA, a 1277-word revision with preliminary task description was produced. Nine intermediate skills were identified and included in the final training protocol. The training content and session evaluations were carried out by 26 experts and 16 final year trainees respectively. While the experts agreed that EST s2/A protocol was well structured (96%), covered the complex endourological manoeuvres (92%) and was useful to optimise and improve hands-on-training sessions (92%), the overall evaluation was scored 4.25/5 by trainees.
We describe the development methodology for intermediate endoscopic stone treatment curriculum, which also provides a roadmap on developing other hands-on training protocols in future.
Journal of endourology. 2021 May 18 [Epub ahead of print]
Domenico Veneziano, Achilles Ploumidis, Ben S E P Van Cleynenbreugel, Ali Serdar Gözen, Joan Palou Redorta, Kemal Sarica, Evangelos N Liatsikos, Roberto Miano, Kamran Ahmed, Guido Kamphuis, Theodoros Tokas, Bhaskar K Somani
Riuniti Hospital, Reggio Calabria, Dept of Urology, Via Giudecca 52, Reggio Calabria, Italy, 89125; ., Athens Medical Center, Urology, Akovis 2, Athens, Greece, 16673; ., UZ Leuven, Belgium, Urology, Herestraat 49, Leuven, Vlaams-Brabant, Belgium, 3000., SLK Kliniken, Urology, am gesundbrunnen 25, Heilbronn, Germany, 74078., cartagena 340Barcelona, Spain, 08025; ., Kartl Lutfi Kırdar Research hospital, Urology, Cevizli, Istanbul, Turkey, 34805; ., University of Patras, 37795, 11 ARETIS GREKOU STR, FILOTHEI, Patras, Greece, 26504; ., Tor Vergata University, Urology, Via Giulio Curioni 131, Rome, Italy, 00157., King's College London, MRC Centre for Transplantation, 5th Floor, Southwark Wing, Guy's Hospital, London, United Kingdom of Great Britain and Northern Ireland, SE1 9RT; ., AMC, urology, Meibergdreef 9, 1105 AZ, Amsterdam, Noord Holland, Netherlands, 1105 AZ; ., Diakonissenkrankenhaus, Urology, Knuthstraße 1, Flensburg, Germany, 24939., University Hospitals Southampton NHS Trust, Urology, Southampton, Southampton, United Kingdom of Great Britain and Northern Ireland, SO16 6YD.